17-44354049-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_198475.3(FAM171A2):​c.2165C>T​(p.Pro722Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000435 in 1,149,316 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000068 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000040 ( 0 hom. )

Consequence

FAM171A2
NM_198475.3 missense

Scores

1
4
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.52

Publications

0 publications found
Variant links:
Genes affected
FAM171A2 (HGNC:30480): (family with sequence similarity 171 member A2) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23932919).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FAM171A2NM_198475.3 linkc.2165C>T p.Pro722Leu missense_variant Exon 8 of 8 ENST00000293443.12 NP_940877.2 A8MVW0
FAM171A2XM_017024490.2 linkc.1613C>T p.Pro538Leu missense_variant Exon 6 of 6 XP_016879979.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FAM171A2ENST00000293443.12 linkc.2165C>T p.Pro722Leu missense_variant Exon 8 of 8 1 NM_198475.3 ENSP00000293443.6 A8MVW0

Frequencies

GnomAD3 genomes
AF:
0.00000678
AC:
1
AN:
147470
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000151
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000399
AC:
4
AN:
1001846
Hom.:
0
Cov.:
30
AF XY:
0.00000424
AC XY:
2
AN XY:
471652
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
19956
American (AMR)
AF:
0.00
AC:
0
AN:
5844
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
10746
East Asian (EAS)
AF:
0.00
AC:
0
AN:
19292
South Asian (SAS)
AF:
0.00
AC:
0
AN:
18876
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
17356
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2488
European-Non Finnish (NFE)
AF:
0.00000460
AC:
4
AN:
869408
Other (OTH)
AF:
0.00
AC:
0
AN:
37880
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000678
AC:
1
AN:
147470
Hom.:
0
Cov.:
31
AF XY:
0.0000139
AC XY:
1
AN XY:
71834
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40930
American (AMR)
AF:
0.00
AC:
0
AN:
14872
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3410
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5074
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8710
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.0000151
AC:
1
AN:
66400
Other (OTH)
AF:
0.00
AC:
0
AN:
2026
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000936
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 06, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2165C>T (p.P722L) alteration is located in exon 8 (coding exon 8) of the FAM171A2 gene. This alteration results from a C to T substitution at nucleotide position 2165, causing the proline (P) at amino acid position 722 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.46
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.0082
T
Eigen
Benign
0.0054
Eigen_PC
Benign
-0.052
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.60
T
M_CAP
Uncertain
0.19
D
MetaRNN
Benign
0.24
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L
PhyloP100
3.5
PrimateAI
Pathogenic
0.92
D
PROVEAN
Benign
-0.71
N
REVEL
Benign
0.063
Sift
Uncertain
0.017
D
Sift4G
Uncertain
0.053
T
Polyphen
0.97
D
Vest4
0.13
MutPred
0.36
Loss of glycosylation at P722 (P = 0.0034);
MVP
0.16
ClinPred
0.83
D
GERP RS
2.8
Varity_R
0.13
gMVP
0.33
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2048406063; hg19: chr17-42431417; API